Anti-tumor Effects of anti-PD-1 Antibody, Pembrolizumab, in Humanized NSG PDX Mice Xenografted With Dedifferentiated Liposarcoma

Integrated whole liver histologic analysis of the allogeneic islet distribution and characteristics in a nonhuman primate model

Comparative study of human and cynomolgus T-cell depletion with rabbit anti-thymocyte globulin (rATG) treatment-for dose adjustment in a non-human primate kidney transplantation model

Multi-layer surface modification of pancreatic islets for magnetic resonance imaging using ferumoxytol.

Relationships between Cytokine Levels and Disease Parameters during the Development of a Collagen-induced Arthritis Model in Cynomolgus Macaques (Macaca fascicularis).

Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells

Reconstituting human cutaneous regeneration in humanized mice under endothelial cell therapy

Reduced variability in pharmacokinetics of tacrolimus following intramuscular injection compared to oral administration in Cynomolgus monkeys: investigating optimal dosing regimens

Establishment of a novel PDX mouse model and evaluation of the tumor suppression efficacy of bortezomib against liposarcoma

Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells

CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus.

Ectopic vascularized bone formation by human umbilical cord-derived mesenchymal stromal cells expressing bone morphogenetic factor-2 and endothelial cells

Effects of Transplanted Islets Nano-Encapsulated with Hyperbranched Polyethylene Glycol and Heparin on Microenvironment Reconstruction and Glucose Control.

Polymeric nano-shielded islets with heparin-polyethylene glycol in a non-human primate model

Three-Dimensional Bioprinting of Hepatic Structures with Directly Converted Hepatocyte-Like Cells.

메타 소프트오간모듈 제작 기술 및 모듈 어셈블리 로봇 시스템 개발

무균/형질전환 돼지의 영장류 이종장기 이식을 통한 이종 장기 임상 적용 가능성 검증

PD-L1에 hyFc 영역을 포함하는 신규 면역억제제 개발 및 사업화